Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis
Clinical trial NCT01000961 · COMPLETED
Trial details
- NCT number
- NCT01000961
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2011-06-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.